Enwei Pharmaceutical Co., Ltd. (SHE:301331)
28.57
+0.72 (2.59%)
At close: Mar 10, 2026
13.60% (1Y)
| Market Cap | 2.89B |
| Revenue (ttm) | 888.64M |
| Net Income (ttm) | 52.06M |
| Shares Out | 101.08M |
| EPS (ttm) | 0.52 |
| PE Ratio | 54.82 |
| Forward PE | n/a |
| Dividend | 0.35 (1.23%) |
| Ex-Dividend Date | Jan 8, 2026 |
| Volume | 753,098 |
| Average Volume | 1,868,679 |
| Open | 28.39 |
| Previous Close | 27.85 |
| Day's Range | 27.73 - 28.60 |
| 52-Week Range | 21.64 - 39.66 |
| Beta | 0.62 |
| RSI | 49.72 |
| Earnings Date | Apr 27, 2026 |